Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about QBiotics Group aggregated by PharmaCompass.com.

    Client Virtual Booth

    QBIOTICS GROUP

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    QBiotics Group
    Australia Flag
    Country
    Country
    Australia
    Address
    Address
    165 Moggill Rd, Taringa 4068 Queensland
    Telephone
    Telephone
    +61 7 3870 8933
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://qbiotics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/qbiotics-group-limited
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Qbiotics To Present At Sachs 9Th Annual Immuno-Oncology Innovation Forum
    Qbiotics To Present At Sachs 9Th Annual Immuno-Oncology Innovation Forum

    https://www.prnewswire.com/news-releases/qbiotics-to-present-at-sachs-9th-annual-immuno-oncology-innovation-forum-and-the-bio-international-convention-301838291.html

    PR NEWSWIRE
    31 May 2023
    Share Share
    New Cancer Treatment For APVMA Approval Of Qbiotics' Stelfonta®
    New Cancer Treatment For APVMA Approval Of Qbiotics' Stelfonta®

    https://www.prnewswire.com/news-releases/new-cancer-treatment-for-australian-dogs-with-apvma-approval-of-qbiotics-stelfonta-301326433.html

    PR NEWSWIRE
    07 Jul 2021
    Share Share
    New Cancer Treatment For APVMA Approval Of Qbiotics' Stelfonta®
    New Cancer Treatment For APVMA Approval Of Qbiotics' Stelfonta®

    https://www.prnewswire.com/news-releases/new-cancer-treatment-for-australian-dogs-with-apvma-approval-of-qbiotics-stelfonta-301326433.html

    PR NEWSWIRE
    07 Jul 2021
    Share Share
    QBiotics enters agreement with MSD to evaluate Tigilanol Tiglat in combo
    QBiotics enters agreement with MSD to evaluate Tigilanol Tiglat in combo

    http://www.pharmabiz.com/NewsDetails.aspx?aid=130406&sid=2

    PHARMABIZ
    14 Aug 2020
    Share Share
    QBiotics Announces Clinical Collaboration with MSD Targeting Melanoma
    QBiotics Announces Clinical Collaboration with MSD Targeting Melanoma

    https://www.prnewswire.com/news-releases/qbiotics-announces-clinical-collaboration-with-msd-targeting-unresectable-melanoma-301111503.html

    PRNEWSWIRE
    12 Aug 2020
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search